MRK Stock Analysis: Buy, Sell, or Hold?
MRK - Merck & Co., Inc.
$124.03
0.49 (0.40%)
▲
5d:
-2.17%
30d:
+4.15%
90d:
+2.15%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Smart Money Accumulation
None View Scanner →
Strength: 8.2/10
Get Alerted When MRK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called MRK this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MRK shows positive signals but monitor for confirmation. Market pricing in 0.4% growth. Moderate conviction.
💡 BUY OPPORTUNITY: MRK shows positive signals but monitor for confirmation. Market pricing in 0.4% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$239.34
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$148.61
16.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MRK is currently trading at $124.03, which is considered fair relative to its 30-day fair value range of $117.27 to $126.99. The stock's valuation (Forward PE: 12.9) is in line with its historical norms (12.8). At these levels, the market is pricing in 0.4% annual earnings growth.
Technical Outlook: Technically, MRK is in a uptrend. The price is currently testing key support at $122.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MRK is in a uptrend. The price is currently testing key support at $122.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$117.27 -
$126.99
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($132.33)
- BULLISH: Expecting earnings turnaround to 0.4% growth with 4.9% revenue growth
Trading Range Analysis
30-Day Trading Range
$117.27 -
$126.99
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$122.44
Resistance Level
$130.29
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.92
Wall Street Target
$132.33
(+6.7%)
Revenue Growth (YoY)
4.9%
Earnings Growth (YoY)
-19.3%
Profit Margin
13.6%
Valuation Premium vs History
+0.4% premium
PE vs Historical
12.9 vs 12.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.4%
(market-implied from PE analysis)
1-Year Target
$124.53
(+0%)
2-Year Target
$125.02
(+1%)
3-Year Target
$125.52
(+1%)
3-Yr Target (if PE normalizes)
(PE: 13→13)
PE COMPRESSION
$124.38
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 251.5%)
$705.80
(+469%)
Base:
(SPY PE: 12.9, Growth: 251.5%)
$418.60
(+238%)
Bear:
(PE: 11.0, Growth: 251.5%)
$355.81
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 35.43 | Current EPS (TTM): $3.53
Bull Case
$275.15
(+123%)
Analyst growth 100.0%, PE expands to 39.0
Base Case
$250.14
(+103%)
Market implied 100.0%, PE stable at 35.4
Bear Case
$85.05
(-31%)
Severe decline -20.0%, PE contracts to 30.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 5:44 PM ET
Data refreshes hourly during market hours. Next update: 6:44 PM
Data refreshes hourly during market hours. Next update: 6:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRK showing a specific setup today?
Insider Activity (6 Months)
2
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-10
Chirfi Guindo
SELL
10000 shares
2026-02-09
Jennifer Zachary
SELL
121573 shares
2026-02-09
Featured in Portfolios
MRK is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1240 | 58 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 64 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$263 | 59 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$223 | 59 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$356 | 56 HOLD |
Advanced MRK Option Strategies
Professional options setups generated by AI based on today's MRK price and gamma walls.
